Hyperbaric Oxygen for Ulcerative Colitis
Status: | Terminated |
---|---|
Conditions: | Colitis, Colitis, Gastrointestinal |
Therapuetic Areas: | Gastroenterology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/17/2018 |
Start Date: | August 2013 |
End Date: | November 2016 |
Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial
The investigators aim to prospectively study the feasibility and clinical impact of
hyperbaric oxygen therapy in acute hospitalized moderate to severe ulcerative colitis flares
as an adjunct to standard medical treatment. Specifically, we will investigate the impact of
hyperbaric oxygen therapy on clinical response/remission and serum and mucosal inflammatory
markers. The investigators expect that hyperbaric oxygen therapy will improve patient
responsiveness to steroids and avoid progression to second line therapy during
hospitalization.
hyperbaric oxygen therapy in acute hospitalized moderate to severe ulcerative colitis flares
as an adjunct to standard medical treatment. Specifically, we will investigate the impact of
hyperbaric oxygen therapy on clinical response/remission and serum and mucosal inflammatory
markers. The investigators expect that hyperbaric oxygen therapy will improve patient
responsiveness to steroids and avoid progression to second line therapy during
hospitalization.
Inclusion Criteria:
- known or newly diagnosed moderate to severe ulcerative colitis with a Mayo score of
greater than 6
- Mayo endoscopic sub-score of greater than or equal to 2
- Risk score of greater than or equal to 4 points
Exclusion Criteria:
- Complication requiring urgent surgical intervention (in the opinion of the
investigators)
Clinically significant cardiac, renal, neurological, endocrine, respiratory or hepatic
impairment in the opinion of the investigator, including but not limited to:
- Pulmonary i. COPD with CO2 retention; Previous/current imaging showing
hyperinflation/air trapping/bullous disease/blebs (opinion of investigators) ii.
Current pneumothorax or previous spontaneous pneumothorax iii. Bronchogenic cyst(s)
- Cardiac i. Uncontrolled HTN (systolic >160 or diastolic >100) ii. Unstable angina or
myocardial infarction within the previous 3 months iii. Ejection fraction < 35% iv.
Current or previous amiodarone use v. ICD in place vi. Pacemaker in place not approved
for chamber use
- Hematological/Oncological i. Current chemotherapeutic drug use, and past history of
bleomycin use. ii. Hereditary Spherocytosis iii. Sickle cell anemia
- Gastrointestinal and Infectious Disease i. Known or suspected Crohn's disease ii.
Previous infection with mycobacterium, fungus, HIV, Hepatitis B or C iii.
Gastrointestinal or systemic infection including, but not limited to, --Clostridium
difficile iv. Current capsule endoscopy or previously non-retrieved capsule
Endocrinology i. Uncontrolled hyperthyroidism
Neurological and Psychological i. Vagal or other nerve stimulators
ii. Uncontrolled seizure disorder
iii. Medications or medical conditions that lower seizure threshold (in the opinion of the
investigator) iv. Drug or alcohol abuse/dependence v. Current treatment for alcohol
cessation with disulfiram vi. Current or recent (within past week) use of baclofen Head and
Neck i. Previous middle ear damage, surgery or infection(s) which may increase the risk for
needing ear tubes (in the opinion of the investigator) ii. Current or previous retinal
detachment or optic neuritis iii. Retinal or vitreous surgery within the past 3 months
Miscellaneous i. Implanted devices not on the approved list for use with HBOT
Women who are pregnant or nursing. Women with childbearing potential were required to use
effective birth control if not surgically sterile or postmenopausal for >2 years.
We found this trial at
3
sites
1 Medical Center Dr
Lebanon, New Hampshire 03756
Lebanon, New Hampshire 03756
(603) 650-5000
Principal Investigator: Corey A Siegel, MD, MS
Phone: 603-650-5261
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
Click here to add this to my saved trials
4200 Fifth Ave
Pittsburgh, Pennsylvania 15260
Pittsburgh, Pennsylvania 15260
(412) 624-4141
Principal Investigator: Jason M Swoger, MD
Phone: 412-648-9173
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Laura E Raffals, MD
Phone: 507-538-0678
Click here to add this to my saved trials